ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
Links shared publicly online about this topic.
- 742total visits
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
View full resource at news-medical.net
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Disease and Condition, Actemra, Genentech, disease
Most Recently Shared on November 8, 2010 at 12:41 pm By:
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/dbhtqB
What are the symptoms and signs of rheumatoid arthritis? | BJC Connected Care
bjchealth.com.au — “Rheumatoid arthritis commonly affects the small joints of the hands and feet in a symmetrical pattern; however, the large joints such as elbows, shoulders,” View full resource at bjchealth.com.au
Most Recently Shared on August 24, 2011 at 6:20 pm By:
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
twurl.nl — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.” View full resource at twurl.nl
Most Recently Shared on November 8, 2010 at 11:36 am By:
Stroke News: ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member ... http://twurl.nl/6p6ovr
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.” View full resource at news-medical.net
Most Recently Shared on November 8, 2010 at 7:28 am By:
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/a270wI
Healthcare Professionals - Rheumatoid Arthritis
remicade.com — “Learn about rheumatoid arthritis and how REMICADE" (infliximab) is indicated for inhibiting joint damage in patients with moderate to severe rheumatoid arthritis.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 5:42 pm By:
Susan Scroggins Health Advocate and Active Health Library
Understanding the pathophysiology of rheumatoid arthritis. Info for health professionals from Remicade. http://bit.ly/9F0A90
Study: Actemra better than placebo in late-stage trial - Related Stories - AAP SmartBrief
smartbrief.com — “More patients who took Roche Holding's Actemra had reduced signs and symptoms of systemic onset juvenile idiopathic arthritis than those given placebo after 12 weeks of treatment in a Phase III trial. The finding adds to evidence of Actemra's efficacy for arthritis, including another late-stage stud” View full resource at smartbrief.com
Most Recently Shared on November 20, 2009 at 11:14 pm By:
Clara Song Physician, Doctor, and Pediatrician
Study: Actemra better than placebo in late-stage trial http://sbne.ws/r/3jBZ
Advertisement
